Drug
Bmn 701
Bmn 701: highest development phase Phase 3, developed by BioMarin Pharmaceutical. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| BMN 701 NCT01924845 | Phase 3 | Late-onset Pompe Disease |
| BMN 701 NCT01230801 | Phase 1/2 | Pompe Disease |
Latest
No recent events.
Follow Bmn 701 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.